ICON Public Limited Company Book Value 2011-2026 | ICLR

Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.

What is included in book value

Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.

Features of the metric

Assessment of the company's "real" value
Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account.
Comparison with market capitalization
Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market.
Indicator of financial stability
If the book value is high, it indicates the company has significant assets, which reduces risks for investors.
Key component for financial ratios
Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.

Annual Book Value ICON Public Limited Company

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
9.52 B	9.24 B	8.5 B	8.07 B	1.85 B	1.66 B	1.35 B	1.19 B	945 M	763 M	950 M	911 M	755 M	682 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
9.52 B	682 M	3.31 B

Quarterly Book Value ICON Public Limited Company

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	8.07 B	8.07 B	7.97 B	2.03 B	1.93 B	1.85 B	1.71 B	1.58 B	1.51 B	1.66 B	1.54 B	1.53 B	1.42 B	1.35 B	1.33 B	1.24 B	1.2 B	1.19 B	1.13 B	1.03 B	945 M	945 M	1.9 B	1.75 B	1.8 B	763 M	1.81 B	1.64 B	1.6 B	1.53 B	1.57 B	1.53 B	1.48 B	1.44 B	1.36 B	1.29 B	1.23 B	1.2 B	1.14 B	1.1 B	1.13 B	1.03 B	1.05 B	1.01 B	1.01 B

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
8.07 B	763 M	1.84 B

Book Value of other stocks in the Diagnostics research industry

Issuer	Book Value	Price	% 24h	Market Cap	Country
Akumin AKU	141 M	-	-17.87 %	$ 25.9 M	Canada
Anixa Biosciences ANIX	14 M	$ 3.11	-2.51 %	$ 101 K	USA
Centogene N.V. CNTG	77.2 M	-	-6.23 %	$ 30.6 M	Germany
Accelerate Diagnostics AXDX	-22.3 M	-	-61.36 %	$ 2.46 M	USA
Brainsway Ltd. BWAY	75.7 M	$ 22.32	-3.71 %	$ 99.4 M	Israel
BioNano Genomics BNGO	35.4 M	$ 1.45	-3.67 %	$ 1.84 M	USA
Aspira Women's Health AWH	6.73 M	-	-6.19 %	$ 10.5 M	USA
Burning Rock Biotech Limited BNR	1.85 B	$ 30.5	-4.72 %	$ 328 M	China
Biocept BIOC	8.86 M	-	-13.05 %	$ 7.29 M	USA
Check-Cap Ltd. CHEK	-1.45 M	-	-	$ 9.42 M	Israel
Castle Biosciences CSTL	456 M	$ 40.78	1.92 %	$ 1.13 B	USA
Co-Diagnostics CODX	86 M	-	-	$ 79.8 M	USA
DexCom DXCM	2.07 B	$ 70.44	1.29 %	$ 27.2 B	USA
Oxford Immunotec Global PLC OXFD	16.7 M	-	-	$ 562 M	Britain
Chembio Diagnostics CEMI	17.8 M	-	0.22 %	$ 16.8 M	USA
Guardant Health GH	-140 M	$ 113.62	1.32 %	$ 13.9 B	USA
Global Cord Blood Corporation CO	4.88 B	-	-	$ 399 M	China
Fluidigm Corporation FLDM	132 M	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	16.4 M	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	548 M	-	0.12 %	$ 80.1 M	China
DermTech DMTK	57.2 M	-	-11.32 %	$ 2.94 M	USA
PRA Health Sciences, Inc. PRAH	1.32 B	-	-	$ 10.7 B	USA
Illumina ILMN	6.3 B	$ 147.36	4.03 %	$ 23.4 B	USA
CareDx, Inc CDNA	261 M	$ 20.08	0.35 %	$ 1.08 B	USA
Danaher Corporation DHR	77.5 B	$ 234.95	-0.44 %	$ 172 B	USA
Celcuity CELC	116 M	$ 105.63	-1.25 %	$ 4.17 B	USA
DarioHealth Corp. DRIO	96.4 M	$ 12.48	0.28 %	$ 354 M	Israel
Enzo Biochem ENZ	56.1 M	-	-8.98 %	$ 14.8 K	USA
Fulgent Genetics FLGT	1.13 B	$ 27.65	-1.53 %	$ 836 M	USA
HTG Molecular Diagnostics HTGM	5.39 M	-	-20.0 %	$ 1.06 M	USA
Exact Sciences Corporation EXAS	2.4 B	$ 102.21	-0.22 %	$ 18.9 B	USA
Lantheus Holdings LNTH	1.09 B	$ 66.02	2.75 %	$ 4.57 B	USA
Medpace Holdings MEDP	826 M	$ 602.32	-1.41 %	$ 18.6 B	USA
IQVIA Holdings IQV	6.07 B	$ 234.18	-1.47 %	$ 42.5 B	USA
QIAGEN N.V. QGEN	6.15 B	-	-	$ 10.6 B	Niderland
Heska Corporation HSKA	422 M	-	-	$ 1.31 B	USA
Neogen Corporation NEOG	2.07 B	$ 9.28	0.27 %	$ 2.01 B	USA
National Research Corporation NRC	49 M	$ 22.06	-0.72 %	$ 541 M	USA
Charles River Laboratories International CRL	3.51 B	$ 219.04	-0.3 %	$ 11.3 B	USA
OPKO Health OPK	1.37 B	$ 1.3	1.56 %	$ 902 M	USA
Pacific Biosciences of California PACB	701 M	$ 2.36	6.79 %	$ 599 M	USA
Quest Diagnostics Incorporated DGX	16.2 B	$ 188.87	-0.33 %	$ 21 B	USA
Biodesix BDSX	20.9 M	$ 8.85	12.25 %	$ 1.15 B	USA
Mettler-Toledo International MTD	-127 M	$ 1 409.56	-3.5 %	$ 29.9 B	Schweiz
Laboratory Corporation of America Holdings LH	8.07 B	$ 272.02	0.42 %	$ 22.8 B	USA
IDEXX Laboratories IDXX	1.6 B	$ 688.67	-3.73 %	$ 56.8 B	USA
Myriad Genetics MYGN	701 M	$ 5.65	-4.56 %	$ 512 M	USA
ENDRA Life Sciences NDRA	2.56 M	$ 4.67	-2.3 %	$ 2.51 M	USA
Agilent Technologies A	5.39 B	$ 135.52	-2.95 %	$ 41.2 B	USA